Articles by Suzanne Hodsden
-
FDA Revises Labeling Regulations For Drugs Used During Pregnancy, Breastfeeding
12/9/2014
The FDA announced a revision to existing system which governs the labeling drug makers must include with prescriptions to explain the risk and benefits of their medications during pregnancy and breastfeeding.
-
Otsuka Acquires Avanir For $3.5B
12/5/2014
Japan-based Otsuka announced the forthcoming acquisition of U.S.-based Avanir in a deal worth $3.5 billion. Otsuka expects the move to broaden their existing portfolio of neurological drugs and broaden their foothold in the U.S. market, Reuters reports.
-
Medicines Patent Pool Signs License Agreement For AbbVie Pediatric HIV Drugs
12/5/2014
The Medicines Patent Pool (MPP), a Swiss non-profit, announced a license agreement with AbbVie for two Pediatric HIV medications, lopinavir and ritonavir.
-
Three Russian HIV Vaccines Proceed To Clinical Trial
12/4/2014
Scientific research at three major Russian research centers in St. Petersburg, Novosibirsk, and Moscow have HIV vaccines in development which are ready to enter into clinical trial, the Russian News Agency Reports.
-
Indian Regulators Hoping To Curb Price of Cancer Drugs in India
12/3/2014
The National Pharmaceutical Pricing Authority (NPPA) in India is seeking advice from the industry on how it can best reduce the price of expensive oncology medications for Indian patients.
-
GPhA President Responds To Recent Generic Drug Cost Criticism
12/3/2014
Ralph Neas, president of the Generic Pharmaceutical Association (GPhA) issued a statement in response to Washtington’s recent probe into the rise of generic drug costs and proposed generic drug legislation.
-
FDA Approves Abuse-Deterring Opioid, Hysingla ER
11/26/2014
The FDA announced its approval of Hysingla ER (hydrocodone bitartrate), an extended release analgesic meant for long-term treatment of severe pain. Purdue Pharma will release the drug with language outlining its abuse-deterrent properties, which is consistent with the FDA’s 2013 guidance.
-
Britain Works To Speed Patient Access To New Drugs
11/25/2014
Three years into Prime Minister David Cameron’s ten-year strategy for boosting life sciences in the U.K., the British government is working with pharma industry leaders to speed patient access to newly approved drugs.
-
Revelations About ZMapp Applicable To Future Ebola Drugs
11/25/2014
New research published this week by Scripps Research Institute (TSRI) gives scientists new insight into the mechanics of ZMapp, an experimental Ebola treatment, which might direct and influence future Ebola drug discoveries.
-
Majority Of Pharma Still Outsourcing Big Data Collection
11/24/2014
Despite the growth of Big Data as an in-house specialty for the pharmaceutical industry, drug companies are still relying on the expertise of outside vendors.